World Leader in Hospital Ultraviolet Disinfection Technology Petitions FDA for Authorization of LightStrike+ Technology
Xenex news release in BusinessWire states it has filed an FDA petition to allow marketing its UV disinfection technology called LightStrike+. SAN ANTONIO–(BUSINESS WIRE)–Xenex Disinfection Services, the world leader in UV disinfection technology for healthcare facilities, today announced it has filed a De Novo petition with the U.S. Food and Drug Administration (“FDA”) for medical device market authorization of its LightStrike+ ultraviolet (UV) room disinfection technology. The company’s patented device uses a xenon lamp to create broad spectrum UV light intended to quickly destroy pathogens on surfaces in healthcare facilities. Xenex’s LightStrike technology is currently being sold pursuant to an FDA enforcement policy…
More from InformationalMore posts in Informational »
- Westmoreland, PA Approves $31 M in Water Treatment Plant Upgrades Including Ultraviolet Disinfection System
- Congressman Sanford D. Bishop Jr. Presents Federally Funded Check to Leesburg, GA to Include UV Wastewater Treatment
- Morro’s Bay, CA Has $160M Water Treatment Online Ahead of Schedule and Includes UV Advanced Oxidation
- Bioaerosol Chamber Disinfected with Ultraviolet Light Between Studies
- PURO UV, Ushio and Johnson Controls Join Forces to Further the Scientific Research of Far UV-C and Validate its Benefits to IAQ